Leonardo Brunetti

机构：Harvard University, Università Campus Bio-Medico, Hammersmith Hospital, Dana-Farber Cancer Institute, Campus Bio Medico University Hospital, Imperial College London · ORCID：0000-0003-2639-4135

发表论文 201 篇 · 总被引 362 次 · h-index 8

代表论文

• Host-related Determinants of Response to Immunotherapy in Non-small Cell Lung Cancer: The Interplay of Body Composition, Metabolism, Sex and Immune Regulation (2025 · Current Oncology Reports · 被引 7)
• Emerging Predictive Biomarkers of Immunotherapy Sensitivity in Patients with Non-Small Cell Lung Cancer (2026 · ImmunoTargets and Therapy · 被引 5)
• A myeloid immunosuppressive phenotype defines primary refractoriness to atezolizumab plus bevacizumab in hepatocellular carcinoma (2026 · Journal of Hepatology · 被引 2)
• PD-(L)1 containing rechallenge strategies in patients with advanced NSCLC previously treated with immunotherapy: A systematic review and meta-analysis across resistance phenotypes (2026 · Cancer Treatment Reviews · 被引 2)
• First-Line Integration of Local Ablative Therapy With EGFR Tyrosine Kinase Inhibitors in Advanced EGFR+ NSCLC: A Systematic Review and Meta-Analysis (2026 · Journal of Thoracic Oncology · 被引 1)
• Data from Clinical Outcomes and Predictors of Response to PD-(L)1 Blockade in Patients with NSCLC without Actionable Genomic Alterations Who Never Used Tobacco (2026)